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Abstract 16	
How G protein-coupled receptors (GPCRs) are organized at the cell surface remains 17	
highly contentious. Single-molecule (SM) imaging is starting to inform this debate as 18	
receptor behavior can now be visualized directly, without the need for interpreting 19	
ensemble data. The limited number of SM studies of GPCRs undertaken to date have 20	
strongly suggested that dimerization is at most transient, and that most receptors are 21	
monomeric at any given time. However, even SM data has its caveats and needs to be 22	
interpreted carefully. Here we discuss the types of SM imaging strategies used to 23	
examine GPCR stoichiometry and consider some of these caveats. We also emphasize 24	
that attempts to resolve the debate ought to rely on orthogonal approaches to 25	
measuring receptor stoichiometry.  26	
 27	
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Introduction 28	
Single molecule microscopy and G protein-coupled receptors 29	
 30	
One of the most powerful approaches for studying protein behavior in situ is single-31	
molecule (SM) microscopy, which allows the tracking of individual proteins at the 32	
cell surface or in model membranes in one or more colors. Typically performed using 33	
total internal reflection fluorescence microscopy (TIRFM) to selectively illuminate 34	
only the basal 100-200 nm of a sample, SM imaging can yield a wealth of data 35	
relevant to the dynamics, distribution, and interactions of cell-surface proteins. In 36	
recent years, improvements in labeling strategies, fluorophores, and microscope 37	
sensitivity have extended the reach of SM imaging at a remarkable pace. 38	
G protein-coupled receptors (GPCRs) represent the largest and 39	
pharmacologically most important family of cell surface receptors encoded by the 40	
human genome. Despite being the focus of intense study for over 20 years, perhaps 41	
the most contentious aspect of GPCR biology concerns their stoichiometry – i.e. 42	
whether they exist as monomers, dimers, or higher-order oligomers. Initially, 43	
Rhodopsin-family (class A) GPCRs were believed generally to be monomeric; 44	
however the present view is now shifted towards a model of dimeric and oligomeric 45	
complexes with distinct signaling behavior in vivo [1, 2]. This is still vigorously 46	
debated, however, mostly because a variety of techniques applied to many GPCRs 47	
have yielded often contradictory conclusions [arguments for and against 48	
oligomerization are summarized in the two articles: 3, 4]. 49	
Thus far, relatively few SM studies of GPCR stoichiometry have been 50	
undertaken, but these have profoundly influenced the debate, contributing to a shift 51	
away from constitutive dimerization toward one based on transient dimerization [5]. 52	
The status these studies have achieved is perhaps due to their being the first to offer 53	
stoichiometric information without the need to interpret bulk data, and the first to 54	
allow stoichiometry to be ‘seen’ directly. Here, we provide an overview of the SM-55	
imaging approaches used to examine GPCR stoichiometry, including their important 56	
limitations, and reflect on their use to date. 57	
 58	
The diffraction limit 59	
 60	
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The principle constraint on conventional SM imaging is that resolution is set by the 61	
Abbe diffraction limit. Fluorophores separated by a distance smaller than this limit 62	
cannot be resolved, and so appear as a single object. Typically, this limit is 200-350 63	
nm, i.e. 1-2 orders of magnitude greater than the diameter of most membrane proteins, 64	
and >20 times greater than the effective resolution of resonance energy transfer (RET) 65	
approaches (5-10 nm; discussed below). This is the most important confounding 66	
factor in the interpretation of SM-based stoichiometric studies, as it is impossible to 67	
distinguish genuine physical interactions from indirect co-localization within the 68	
resolvable distance. Super-resolution imaging-based SM approaches may eventually 69	
overcome this issue but have as yet had only a modest impact. 70	
 71	
Measuring stoichiometry despite the diffraction limit 72	
Three methods are usually employed to determine the number of GPCRs within a 73	
fluorescent ‘spot’: spot-intensity analysis, photobleaching step counting, and two-74	
color coincidence detection (TCCD; Figure 1). Spot-intensity analysis measures the 75	
absolute intensity of each spot and compares it to that for a single fluorophore. This 76	
approach is often combined with photobleaching-step counting, wherein the number 77	
of fluorophores in a spot is determined from the number of discrete intensities 78	
observed in the course of complete photobleaching. In TCCD experiments, receptors 79	
are labeled in two colors and the degree of co-localization between spots of opposite 80	
colors is measured [6]. Spots can also be tracked over time to allow their coincident 81	
movement to be observed. 82	
 These three approaches are presently the most effective means of determining 83	
stoichiometry in diffraction-limited SM imaging-based experiments, and yet none are 84	
without confounding issues of interpretation. In the first instance, more efficient 85	
detection of brighter spots could conceivably introduce bias. For example, this might 86	
involve the inappropriate use of thresholding below which weaker signals are 87	
discounted, or through subtler effects arising from the brightness and stability of the 88	
fluorophore used (see ‘Labeling considerations’). In intensity or photobleaching 89	
analyses this can skew the experiment toward detecting oligomers, since monomers 90	
will more likely go undetected. In TCCD, on the other hand, fewer dimers will be 91	
detected, as species containing two receptors of the same color will be preferentially 92	
detected, and counted as monomers. Similarly, all three analyses are sensitive to 93	
labeling efficiency, which must be taken into consideration. Most importantly, these 94	
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approaches only determine the number of receptors within a diffraction-limited area, 95	
not whether co-localization is direct (i.e. involving physical contact) or indirect (i.e. 96	
as a result of either chance proximity effects or ‘third-party’ associations); 97	
stoichiometry is therefore not reported directly. 98	
 99	
Dealing with indirect co-localization 100	
Researchers generally use two approaches to allow for indirect co-localization: 101	
simulations from first principles, and references to known controls. Monte Carlo 102	
simulations are used to determine the probable fraction of receptors co-localized by 103	
chance at the observed receptor densities. If particles are tracked over time, the 104	
likelihood of coincident movement due to chance can also be calculated by reference 105	
to the observed diffusional behavior. These models assume free diffusion and 106	
homogenous distribution of the receptors, with no anomalous behavior or interactions 107	
with ‘third-party’ proteins. They therefore tend to report expected background indirect 108	
co-localization levels that are very low [e.g. 7, 8]. 109	
  However, it is now accepted that membrane proteins do not always exhibit 110	
free diffusion and can be highly constrained due to interactions with actin and/or other 111	
membrane/cytoskeletal elements [9-11]. In many cases, membrane proteins are 112	
heterogeneously distributed due to compartmentalization effects, ranging from small-113	
scale ‘clustering’ to the large-scale effects of cell polarization. GPCR distributions are 114	
still poorly understood with regard to such effects, but there are reports of highly 115	
confined diffusion [12, 13], topologically-defined distribution [14, 15], and/or actin-116	
dependent clustering [16]. The functional implications of these types of organization 117	
are still unclear. Differences in β-adrenergic receptor (βAR) organization in cardiac 118	
myocytes may explain subtype-specific variation in signaling behavior [17, 18], and 119	
alleviation of receptor segregation from signaling partners has been reported to 120	
increase basal signaling activity [19]. Irrespective of its functional importance or 121	
otherwise, the effects of nano- and micro-scale GPCR organization indicates that free-122	
diffusion based modeling is likely incomplete, leading to substantial under-estimates 123	
of indirect co-localization or coincident movement and non-interacting receptors 124	
being incorrectly identified as oligomers. 125	
 The use of stoichiometric controls establishes the dynamic range of an 126	
experiment, allowing receptor stoichiometry to be assigned more rigorously. An 127	
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advantage of this approach over simulations is that it accommodates inefficiencies in 128	
labeling, or biases in spot detection, if the same labeling and detection strategies are 129	
used for controls and samples. Nonetheless, controls must be selected carefully to 130	
maximize similarities with sample receptors, since significant differences in either 131	
distribution or dynamics could alter their apparent stoichiometry relative to receptors 132	
of interest, rendering them unsuitable as controls. Unfortunately, this is not generally 133	
feasible in the case of Rhodopsin-family GPCRs, for which there are no agreed 134	
stoichiometric ‘exemplars’, and so researchers are limited to unrelated controls. The 135	
Glutamate-family GPCR γ-aminobutyric acid b receptor 2 (GABAbR2) is a well-136	
established dimer [20, 21] used in a number of SM experiments [22, 23]. Monomer 137	
controls, however, have to be drawn from other protein families, typically type I 138	
transmembrane proteins [22, 23]. Whilst not ideal, these are nonetheless more 139	
appropriate controls than lipids [8], which exhibit vastly different diffusional 140	
properties versus transmembrane proteins. Finally, fixation removes the variable of 141	
differing dynamics between controls and samples [discussed at length in 22] leaving 142	
only nanoscale organization as a variable, which cannot be controlled for. Moreover, 143	
fixation precludes the study of dynamic processes, e.g. transient association. 144	
In short, there is no perfect way to estimate the indirect co-localization rate in 145	
SM studies. Comparison to multiple well-characterized controls, on fixed cells, seems 146	
at the moment to be the best available option.  147	
 148	
Labeling considerations 149	
 150	
The second major factor affecting the interpretation of SM studies is labeling strategy. 151	
GPCR labeling strategies have recently been exhaustively reviewed by Tian et al. 152	
[24]; however only a subset of these is suitable for stoichiometric analyses. The key 153	
issues for this are labeling efficiency, fluorophore brightness and stability, and tagged 154	
receptor activity. These matters are relevant to all SM experiments, but are 155	
particularly important in studies of stoichiometry since the outcome will be highly 156	
dependent on the fraction of detected receptors. Low labeling efficiency or 157	
photobleaching caused by poor fluorophore stability will lead to a substantial fraction 158	
of undetectable receptors, risking bias toward lower stoichiometry. Conversely, low 159	
fluorophore brightness can lead to overestimates of oligomer frequency since singly-160	
tagged monomers will be more likely to go undetected.  161	
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 162	
Ligand-based strategies 163	
Near-perfect tagging of all cell-surface receptors on a given cell can be achieved with 164	
high-affinity, fluorophore-conjugated ligands, especially since a large number of 165	
bright, photostable fluorophores can be used. This approach has the major advantage 166	
of allowing investigation of endogenous receptors in native tissues, although target 167	
specificity needs to be confirmed to avoid the misidentification of off-target receptors. 168	
Moreover, fluorescent ligands are inherently intrusive, preclude the examination of 169	
GPCRs in the unliganded state, and are likely, unavoidably, to alter the behavior of 170	
target receptors. For example, the use of fluorescent agonists will lead to activation-171	
driven internalization and/or clustering, shifting the apparent stoichiometry toward 172	
oligomers. This has been overcome in the past using internalization-deficient mutants 173	
[8] or by reconstituting receptors in high density lipoprotein particles [25], sacrificing 174	
a degree of physiological relevance. Nonetheless, even under these approaches the 175	
possibility exists that negative cooperativity (such that binding of one ligand to a 176	
dimer inhibits binding of a second [26]) may reduce apparent stoichiometry. 177	
Fluorescent antagonists have been used in studies of the M1 muscarinic receptor and 178	
dopamine D2 like receptor (D2L) expressed in Chinese Hamster Ovary (CHO) cells 179	
[7, 27], and the M2 receptor in primary mouse cardiomyocytes and cardiac tissue 180	
slices [28]. Antagonists, as opposed to inverse agonists, should not alter basal receptor 181	
activity and therefore, in principle, offer the best GPCR ligand-based labeling 182	
strategy. However, antagonists could in principle still interfere with receptor 183	
organization, and the ligand-based approach also precludes the use of stoichiometric 184	
controls as only the receptor of interest can be studied.  185	
 186	
Genetically encoded fusion proteins 187	
The obvious alternative to ligand-based labeling strategies is to use genetically-188	
encoded fusion proteins. This is generally less perturbative than using fluorescent 189	
ligands, but it requires expression in non-native cells to avoid the complication of 190	
interactions with unlabeled native receptors. Most often, human GPCRs have been 191	
transfected into CHO cells [e.g. 7, 22, 23, 29], thereby avoiding this problem, albeit at 192	
the cost of removing the receptors from their native context. It is unclear to what 193	
extent GPCR stoichiometry is cell-dependent, but it could in principle be influenced 194	
by cellular context, e.g. due to differences in membrane lipid environment [30] or 195	
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altered interactions with third-party proteins. An additional consideration is receptor 196	
density. SM imaging requires low densities allowing resolution of individual 197	
fluorophores and the minimization of indirect co-localization effects. However, 198	
transient dimerization could be highly dependent on receptor concentration, such that 199	
unphysiologically low densities might shift equilibria towards monomers. Examining 200	
a range of densities is the ideal approach but this might not always be feasible. 201	
Several tagging strategies are suitable for SM imaging. Fluorescent proteins 202	
have the advantage of high labeling efficiency although they are typically less bright 203	
and/or photostable than inorganic dyes. Moreover, labeling is not necessarily 204	
complete since many fluorescent proteins exhibit imperfect folding and/or maturation 205	
[31, 32]. Receptors that are unlabeled due to misfolding of the attached fluorescent 206	
protein or photobleaching may reduce the apparent stoichiometry, whereas the 207	
relatively low brightness of some fluorescent proteins favors the detection of spots 208	
containing multiple receptors. It is therefore essential that analogously labeled 209	
stoichiometric controls are used to determine the dynamic range of the experiment.  210	
The option of using brighter fluorophores is provided in the form of versatile 211	
enzyme-based fusion tags e.g. SNAP-tag [33], CLIP-tag [34], and HaloTag [35], each 212	
of which allows irreversible labeling with a series of inorganic dyes. Although bright 213	
and stable, labeling is relatively inefficient, meaning that stoichiometry can only be 214	
determined with reference to controls of known stoichiometry. Labeling efficiency 215	
varies substantially between C-terminal [<60%; 22] and N-terminal tags [<100%; 23] 216	
due to the relative availability of ligand inside and outside the cell. The improved 217	
labeling efficiency of extracellular tagging can come at the considerable cost of 218	
folding efficiency, however, because the N-terminal domain and associated 219	
transmembrane helix 1 are among the most folding-sensitive regions of GPCRs [36] 220	
and membrane transfer of the heterologous, fluorescent protein during translation can 221	
interfere with receptor folding [37]. In our experience, N-terminally tagged GPCRs 222	
frequently express and, by implication, fold less well than C-terminally tagged 223	
equivalents (unpublished data). This is likely to seriously hamper interpretations of 224	
stoichiometry because partial folding can induce aggregation and the false 225	
identification of oligomers. An alternative N-terminal labeling approach is to fuse 226	
receptors to small epitope tags, allowing post hoc targeting with fluorophore-227	
conjugated monovalent antibody fragments [38]. 228	
 229	
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SM studies of GPCR stoichiometry 230	
 231	
Initial studies of muscarinic receptors 232	
The first in situ SM analysis of GPCR stoichiometry was published by Hern et al. in 233	
2010 [7] (a full list of SM imaging studies of GPCR stoichiometry is presented in 234	
Table 1). Their analysis of Cy3B antagonist-bound M1 revealed that >80% of spots 235	
had intensities consistent with single fluorophores, which exhibited single-step 236	
photobleaching. The remainder comprised spots likely to contain two antagonists 237	
(~8%), and others exhibiting apparent transitions between monomer and dimer states. 238	
TCCD-based analysis of mobile receptors labeled in two colors showed that ~80% 239	
exhibited independent movement, with the others diffusing coincidentally. The 240	
authors concluded that M1 receptors are predominantly monomeric, with ~30% of 241	
receptors forming short-lived dimers at any one time. 242	
 These observations were very important because they broke the hegemony in 243	
favor of constitutive M1 dimerization based previously on RET and co-244	
immunoprecipitation experiments [e.g. 39]. The labeling approach meant that it was 245	
highly unlikely that the monomer population was overestimated as the fraction of 246	
unlabeled receptors was negligible. However, comparative stoichiometric controls 247	
were not possible, and so the extent if any of indirect co-localization had to be 248	
estimated using simulations. The probability of chance coincidence thus calculated 249	
was <1%, suggesting that the observed dimer fraction was largely genuine. Hern and 250	
colleagues justified their assumption of free diffusion by observing that the mean 251	
square displacement of receptors was linearly proportional to time, consistent with a 252	
random walk. However, as discussed above, it is unclear how reliable this assumption 253	
is. Slower diffusion of M1 upon dimerization was observed, as required by the 254	
Saffman-Delbrück model [40], consistent with genuine association. However, reduced 255	
diffusion might also have been caused indirectly by association with e.g. cytoskeletal 256	
proteins or membrane domains. 257	
The same team subsequently performed the first SM investigation of GPCRs 258	
in native cells by probing M2 muscarinic receptors in mouse cardiomyocytes [28]. 259	
Photobleaching analysis revealed similar behavior to M1 in CHO cells: ~74% 260	
monomers in perinatal cardiomyocytes and ~57% in newborn myocytes. The 261	
remainder exhibited two-step photobleaching, whereas multi-step bleaching was not 262	
observed. This also confirmed that GPCRs do not constitutively dimerize in situ, in 263	
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contrast to conclusions based on a photobleaching-step analysis of isolated, 264	
immobilized M2 receptors suggesting tetrameric organization [41]. Nonetheless, the 265	
problem of how to interpret the apparent dimers remained. Indeed, the authors noted 266	
that the fraction of dimeric tracks increased with receptor density. This could arise 267	
either from a dynamic monomer-dimer equilibrium driven by a first-order binding 268	
process, or from increasing indirect coincidence at higher densities, or both. 269	
Intriguingly, the diffusion of M2 in isolated primary cardiomyocytes was ~4-fold 270	
slower than in fresh cardiac tissue slices, highlighting the need for studying receptors 271	
in their native settings.        272	
 273	
Subsequent SM studies reporting mostly monomers 274	
The original investigation by Hern et al. was followed shortly after by a similar 275	
analysis of an internalization-deficient N-formyl peptide receptor (FPR) expressed in 276	
CHO cells, labeled using a fluorescent agonist peptide [8]. Once again, ~60% of 277	
detected objects had intensities characteristic of monomers, consistent with previous 278	
observations [42]. The remaining ~40% of receptors behaved as dimers with average 279	
lifetimes far shorter than that of M1 [7]. Like Hern et al., simulations of free diffusion 280	
were used to determine the chance coincidence rate. The authors did use monomeric 281	
controls, but one of these was an unsaturated phospholipid unlikely to exhibit similar 282	
distribution and diffusional properties to FPR, and the other was labeled with an 283	
alternative fluorophore, precluding direct intensity comparisons.  284	
 Comparable fractions of monomeric receptors were subsequently reported by 285	
Tabor et al. for D2L labeled with an N-terminal SNAP-tag and fluorescent ligands, 286	
expressed in CHO cells [27]. Spot-intensity analysis revealed ~70% monomers and 287	
~30% apparent dimers, depending slightly on receptor density. A monomer control 288	
(the type I membrane protein, CD86) reported only 5% dimers. Similarly, ~80% and 289	
~90% of the related D2S and D3 receptors behaved as monomers, respectively. Spot-290	
intensity analysis of GFP-tagged apelin receptors in CHO cells also implied that 291	
monomers were the largest single population present, comprising 40% of receptors, 292	
with 36% forming apparent dimers, and 24% oligomers [29]. However, the 293	
contribution of indirect co-localization was not addressed.  294	
   The extent to which indirect co-localization might have affected the 295	
interpretation of each of these studies is difficult to estimate. A study using fixed cells 296	
and benchmarking with monomeric and dimeric controls examined C-terminally 297	
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Halo- and SNAP-tagged β2AR and mCannR2 expressed in HEK 293T and CHO cells 298	
[22]. TCCD analysis showed that neither GPCR exhibited coincidence above that of a 299	
monomeric control protein, whereas the two dimer controls exhibited coincidence 300	
levels 2-3 fold higher. Significantly, and similar to the observations of Tabor et al. 301	
[27], the monomer control (CD86) exhibited ~8-10% coincidence, showing that even 302	
known monomers exhibit a degree of indirect co-localization. This was the first in situ 303	
SM analysis to report the absence of detectable dimerization for any Rhodopsin-304	
family GPCR. This analysis has more recently been extended to β1AR and the 305	
lysophosphatidic acid receptor 1 (LPA1), which behaved as monomers; and the 306	
closely related α2C-adrenergic receptor (α2CAR) and sphingosine-1-phosphate receptor 307	
3 (S1P3), which behaved as dimers [43]. It is also noteworthy that a purified and 308	
functionally reconstituted GPCR, the µ-opioid receptor (µ-OR) also failed to self-309	
organize, indicating that at a protein-intrinsic level, this receptor is monomeric [25].  310	
 311	
A SM study reporting predominantly oligomers 312	
Whilst there is some uncertainty about the authenticity of the GPCR oligomers 313	
observed in SM studies done to date there is, however, the consistent finding that 314	
dimerization is not constitutive. Indeed, only one SM study reports that a receptor 315	
forms mostly dimeric/oligomeric complexes. N-terminally SNAP-tagged β1AR and 316	
β2AR expressed in CHO cells were subjected to spot-intensity analysis by Calebiro et 317	
al., and 30-85% of β1AR, and 60-100% of β2AR receptors exhibited intensities 318	
greater than that expected for monomers. At high densities both receptors formed 319	
apparent trimers, tetramers, and higher-order oligomers. Indirect co-localization was 320	
addressed using free diffusion-based simulations.  321	
As the only GPCRs examined in multiple separate SM analyses, it is striking 322	
that the studies of β1AR and β2AR by Calebiro et al., and by Latty et al. and Felce et 323	
al., have produced such different outcomes. The reasons for the discrepancies are 324	
difficult to ascertain since there were many differences between the approaches taken, 325	
including the measurement strategy (intensity analysis vs. TCCD), expression system 326	
(stable vs. transient), cell context (live vs. fixed), and labeling strategy (N-terminal vs. 327	
C-terminal). As discussed above, it is possible that N-terminal labeling of βARs by 328	
Calebiro et al. resulted in partial aggregation of the receptors leading to increased 329	
detection of oligomers. The authors reported normal receptor responses to ligand, 330	
suggesting that at least some of the βARs were active, but not necessarily all. 331	
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Alternatively, the use of intensity analysis rather than TCCD could explain the higher 332	
levels of apparent receptor oligomerization if detection bias for brighter spots was 333	
introduced into the analysis. The observation that 0% of a double-labeled dimer 334	
control used by Calebiro behaved as a monomer offers some support for this view, 335	
because a degree of monomeric behavior should have been observable due to 336	
imperfect labeling efficiency. The SNAP-tag used by Calebiro et al. is a derivative of 337	
the DNA repair protein O6-alkylguanine-DNA alkyltransferase [33], and undergoes 338	
low level conjugation to non-fluorescent benzylguanine moieties within the cell, 339	
precluding 100% fluorescence labeling. A final, formal possibility is that the labeling 340	
efficiencies, determined only for the controls in Latty et al. and Felce et al., differ for 341	
the controls versus the GPCRs studied, although there are no reports of Halo- or 342	
SNAP-tag labeling being dependent on their fusion partners. 343	
 344	
Super-resolution based studies  345	
 346	
Presently, SM super-resolution imaging comprises photoactivated localization 347	
microscopy (PALM) and stochastic optical reconstruction microscopy (STORM), 348	
which temporally separate emission from individual fluorophores to allow calculation 349	
of position with sub-diffraction precision. Applied to stoichiometric measurements, 350	
the effective resolution of PALM/STORM experiments (10-30 nm) offers greater 351	
discrimination between genuine interactions and indirect co-localization. On this scale 352	
the chance co-localization rate for randomly distributed GPCRs at typical densities 353	
(0.1-1 receptors/µm2) is effectively zero. Nonetheless, the method cannot yet 354	
distinguish between directly interacting receptors and those interacting locally with a 355	
common partner (e.g. actin). Super-resolution imaging is also vulnerable to reporting 356	
artifactual protein clustering due to imperfect fixation [44, 45], or repeated detection 357	
of a fluorophore due to stochastic blinking behavior [46]. 358	
 The first PALM-based study of a GPCR measured the fraction of β2AR 359	
molecules in >5 molecule clusters rather than base stoichiometry per se, reporting that 360	
clustering varied significantly between cell types [16]. Cryogenic localization 361	
microscopy has been used to examine relative spacing of receptors within dimers [27] 362	
but only recently has GPCR stoichiometry been directly examined using super-363	
resolution SM imaging [38]. Jonas et al. examined the luteinizing hormone receptor 364	
(LHR) tagged N-terminally with epitope tags bound by antibodies conjugated to 365	
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photoactivatable dyes. Using PALM, they localized receptors with a precision of ~20 366	
nm, representing an ~10-fold improvement over diffraction-limited SM approaches, 367	
and found that ~14% of LHR spots associated with another (consistent with 368	
dimerization) while ~27% associate with >1, including ~10% within clusters of >9 369	
receptors. By analyzing the spot separation within trimeric and tetrameric clusters 370	
they proposed a model of protomer assembly producing a diverse range of receptor 371	
complexes. Importantly, however, ~60% of LHR is wholly monomeric, consistent 372	
with most SM studies. Whether the observed associations represent bona fide 373	
interactions is unclear. Although the levels of indirect co-localization for randomly 374	
distributed receptors at this resolution is extremely low, the authors acknowledge that 375	
observed oligomers may be the product of receptor clustering at some form of 376	
membrane or cytoskeletal structure. A monomeric control also exhibited a dimeric 377	
fraction of ~11%, marginally lower than LHR (~14%), suggesting that a fraction of 378	
the detected dimers were the product of indirect co-localizations. Low-level clustering 379	
detected as higher-order oligomerization might result from basal receptor activity [a 380	
common feature of GPCRs; 47]. The observation that a signaling-deficient mutant 381	
produced more monomeric behavior when in excess over a binding-deficient mutant 382	
is consistent with such an effect, as the reduced basal signaling would likely lead to 383	
relaxed clustering and fewer apparent oligomers. 384	
 385	
The value of orthogonal approaches 386	
 387	
SM imaging has, of course, emerged alongside existing methods of stoichiometric 388	
analysis. In bimolecular fluorescence complementation (BiFC), which has been 389	
employed in parallel with conventional SM imaging in a number studies, two inactive 390	
fluorescent-protein fragments form a fluorescent complex when fused to interacting 391	
pairs of proteins.  However, a significant problem with BiFC is that the formation of 392	
the fluorescent complex is essentially irreversible [48-50], and so capable of 393	
stabilizing non-physiological interactions of membrane proteins. Kasai et al. [8] and 394	
Cai et al. [29] have used BiFC to analyze the FPR and the apelin receptor, 395	
respectively. Since Kasai et al. found that fluorescent BiFC spots had average 396	
lifetimes of 301 ms (three-fold longer than observed in their SM tracking 397	
experiments) it seems that there could have been a degree of complex stabilization, 398	
confounding interpretation of the data. 399	
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 Arguably, studies utilizing the RET-based assays Förster (FRET) and 400	
bioluminescence RET (BRET) have had the largest impact on the stoichiometry 401	
debate. Energy transfer efficiencies (RETeff) between donor and acceptor molecules is 402	
negligible above a separation distance of 5-10 nm, conferring upon RET assays an 403	
effective resolution far superior to that of SM imaging. RET-based assays are 404	
therefore highly complementary to the SM approach. However, the interpretation of 405	
RET assays of membrane proteins is also complicated by indirect interactions. 406	
Remarkably, expressed as ‘BRET pairs’, monomers exhibit BRETeff equivalent to 407	
~25% that of covalent dimers [51], and so the occurrence of RET alone cannot be 408	
used to infer oligomerization. Nonetheless, RET alone, both in transfected cell 409	
systems [e.g. 52, 53] and native tissues [e.g. 54] has, even in the recent past, been 410	
used as the sole basis for claiming oligomerization.  411	
Most RET studies now attempt to distinguish specific and non-specific RET 412	
using several approaches. The most common is the BRET saturation assay, wherein 413	
donor concentration is kept constant and acceptor levels are systematically increased 414	
[55]. Despite widespread use, its reliance on distinguishing between a pseudolinear 415	
increase in BRETeff for monomers and a hyperbolic one for dimers greatly 416	
complicates the interpretation of this type of data [56]. First, distinguishing between 417	
two systematically increasing signals can be difficult unless the data are of 418	
exceptional quality. Second, the assumption of pseudolinearity for monomeric 419	
proteins can be unsafe in certain circumstances at high receptor expression [57]. We 420	
have described elsewhere BRET assays that circumvent these issues by maintaining 421	
either a constant receptor density (the ‘type-1’ assay) or constant acceptor:donor ratio 422	
[the 'type-2' assay; 51, 56]. The principle of the type-1 assay is illustrated in Figure 423	
2a, and its ability to distinguish between monomers and both transient and covalent 424	
dimers illustrated in Figure 2b. We have also developed an adapted competition assay 425	
[the 'type-3' assay; 57], which uses untagged ‘competitor’ proteins to disrupt genuine 426	
BRET-productive association whilst accounting for the effect of competitors on the 427	
expression of tagged proteins. In these types of assays, for well-behaving proteins and 428	
with the use of suitable controls, it is a straightforward matter to distinguish between 429	
monomers and dimers. BRET assays also offer the advantage, over SM methods, of 430	
being implementable in semi-high-throughput settings, allowing large scale 431	
comparative studies [43]. The debate over the correct implementation of BRET for 432	
stoichiometric analysis [58-60] has, we suspect, somewhat diminished enthusiasm for 433	
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this general approach. This would be unfortunate if true because, used in the right 434	
way, these assays are very powerful tools in their own right, and especially well-435	
suited to validating conclusions derived from SM imaging.  436	
 437	
Future perspectives 438	
 439	
The most pressing current need is for a broader range of receptors to be tested using 440	
SM imaging to build up a clearer model of GPCR organization and behavior, 441	
particularly through increasingly unambiguous super-resolution approaches. 442	
Alongside super-resolution imaging technology per se, significant advances in 443	
receptor labeling may increase the power of the SM approach. To improve spatial 444	
resolution, DNA-PAINT (point accumulation for imaging in nanoscale topography) 445	
uses transient binding of short fluorescent oligonucleotides to DNA-tagged proteins to 446	
greatly increase overall photon count, and therefore localization precision [61]. The 447	
~5 nm achievable resolution of DNA-PAINT could potentially report GPCR 448	
stoichiometry on a single-receptor scale, overcoming many of the interpretive issues 449	
of lower-resolution approaches discussed here. Similarly, multicolor quantum dot 450	
ligands for the HaloTag labeling system offer far greater temporal resolution than 451	
current approaches due to their extreme photostability [62], and will likely provide 452	
greater insight into possible transient dimerization, if this occurs. This, and other 453	
genetic tagging strategies, will be facilitated by Cas9-targeted homology directed 454	
repair [63], allowing their use in native cells, away from potentially inappropriate 455	
cellular contexts. This will also ensure native receptor expression levels, which will 456	
be advantageous because the physiological concentrations of most GPCRs are not 457	
well understood, and most studies have not performed density-dependent 458	
measurements that would allow extrapolation to a range of densities. In general, a 459	
move towards examining receptors in primary cells is important given the possibility 460	
that the distribution of some GPCRs might be controlled in native tissues. Indeed, it 461	
will be the combination of stoichiometry and microscale organization that will be 462	
vital to fully understanding GPCR behavior, since organization may be equally or 463	
more important than stoichiometry for regulating some receptors [e.g. 15, 64].  464	
 465	
Concluding Remarks 466	
 467	
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The debate about GPCR stoichiometry has been ongoing since the first suggestions of 468	
generalized dimerization fifteen years ago [65, 66]. SM imaging entered the discourse 469	
relatively recently, at a time when many, often contradictory biochemical and 470	
biophysical studies had failed to produce a clear consensus (see ‘Outstanding 471	
Questions’). The insights generated by the small number of published GPCR SM 472	
studies have already been substantial; but even the critical interpretation of these data 473	
is not trivial. It seems likely, therefore, that a satisfactory answer to the GPCR 474	
stoichiometry question will depend heavily on SM imaging, supported by other 475	
technologies. The more different ways we can make our observations, the more 476	
confidence we can have in the answers we obtain. The truth will be marked by a 477	
convergence of observations. 478	
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FIGURE LEGENDS 666	
 667	
Figure 1 – SM imaging-based approaches to determining protein stoichiometry. (A) 668	
In single-color experiments, spots are detected in one channel for one or more frames. 669	
The four panels depict the simulated step-wise photobleaching of a monomer (i), 670	
dimer (ii), and trimer (iii) over time, at a constant rate (loss of one fluorophore from 671	
each object per panel). (B) Intensity analysis gives the number of labeled proteins in a 672	
spot by comparing the starting (i.e. unbleached) fluorescence to that of a single 673	
fluorophore. Spots should exhibit discrete intensity levels corresponding to multiples 674	
of the single fluorophore intensity (i.e. i = 1 fluorophore, ii = 2, iii = 3). Simulated 675	
data is shown. (C) Photobleaching-step counting requires spot tracking for multiple 676	
frames, during which photobleaching should occur in discrete steps corresponding to 677	
the bleaching of individual fluorophores in the spot (i.e. i = 1 bleaching event, ii = 2, 678	
iii = 3). Simulated data is shown. (D) TCCD involves detecting spots in two colors 679	
and determining the fraction of spots in one color that are within a specified radius of 680	
spots in the other color. This yields a coincidence value that is then compared to those 681	
of known stoichiometric controls. The three panels depict simulated images of 682	
receptors labeled in two colors at a constant 4:4 red:green ratio. The fraction of red 683	
spots identified as coincident below each panel corresponds to the number of spots 684	
comprising at least one receptor in each color (white arrows) divided by the total 685	
number of spots comprising at least one red receptor.  686	
 687	
Figure 2 – Principles of the type-1 BRET assay. (A) In a type-1 BRET experiment, 688	
acceptor/donor ratio is increased but surface density is kept constant by exchanging 689	
donors for acceptors (as indicated within the red circles). For a monomer, BRETeff is 690	
unchanged, whereas for a dimer BRETeff increases as the fraction of productive 691	
dimers increases. Donor-tagged proteins are represented as blue circles with a BRET-692	
permissive halo. Fluorescing and non-fluorescing acceptors are illustrated as green-693	
filled or white-filled circles, respectively. BRETeff (calculated under each panel) is 694	
determined as the fraction of donor molecules within the BRET-permissive radius of 695	
one or more acceptor molecules. (B) Characteristic type-1 BRET data for monomeric 696	
transmembrane proteins (CD86, CD2), and for transient (CD80), or covalent (CD28) 697	
transmembrane protein dimers. The relationship between BRETeff and acceptor:donor 698	
ratio matches a hyperbolic fit (solid line) for dimers but is invariant above a 699	
acceptor:donor ratio of ~2 (broken line) for monomers, consistent with the model 700	
shown in Figure 2A. Data reproduced with permission from James et al., 2006 [51]. 701	
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